These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 17827665)

  • 1. N-glycosylthioureido aglyco-ristocetins without platelet aggregation activity.
    Sztaricskai F; Pintér G; Röth E; Herczegh P; Kardos S; Rozgonyi F; Boda Z
    J Antibiot (Tokyo); 2007 Aug; 60(8):529-33. PubMed ID: 17827665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Ability of vancomycin-group antibiotics to induce or to inhibit thrombocyte agglutination].
    Rák K; Boda Z; Sztaricskai F
    Antibiotiki; 1980 Aug; 25(8):595-606. PubMed ID: 6250464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Click reaction synthesis of carbohydrate derivatives from ristocetin aglycon with antibacterial and antiviral activity.
    Pintér G; Bereczki I; Batta G; Otvös R; Sztaricskai F; Roth E; Ostorházi E; Rozgonyi F; Naesens L; Szarvas M; Boda Z; Herczegh P
    Bioorg Med Chem Lett; 2010 May; 20(9):2713-7. PubMed ID: 20381348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of platelet agglutination induced by the antibiotics of the vancomycin group: ristocetin, ristomycin, actinoidin and vancomycin.
    Boda Z; Solum NO; Sztaricskai F; Rak K
    Thromb Haemost; 1979 Dec; 42(4):1164-80. PubMed ID: 232315
    [No Abstract]   [Full Text] [Related]  

  • 5. Destruction of the platelet aggregating activity of ristocetin A.
    Kuwahara S; Chambers WT
    Experientia; 1978 Apr; 34(4):532-4. PubMed ID: 565300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Inhibitory effect of kallikrein on ristocetin-induced platelet aggregation (author's transl)].
    Fukutake K; Ukita M; Kitamura T; Yamaguchi I
    Nihon Ketsueki Gakkai Zasshi; 1979 Jun; 42(3):549-50. PubMed ID: 495016
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparative studies of available ristocetins: proteolytic activity and effect on platelets.
    Jenkins CS; Meyer D; Ardaillou N; Lombard C; Larrieu MJ
    Thromb Res; 1975 Oct; 7(4):531-42. PubMed ID: 1081758
    [No Abstract]   [Full Text] [Related]  

  • 8. Biological properties of ristocetin-ps-aglycone.
    Nielsen RV; Hyldig-Nielsen F; Jacobsen K
    J Antibiot (Tokyo); 1982 Nov; 35(11):1561-4. PubMed ID: 7161195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impairment of ristocetin-induced platelet aggregation in patients with infective endocarditis.
    Matsumoto M; Murakami H; Matsushima T; Tamura J; Sadakata H; Narahara N; Sawamura M; Naruse T; Tsuchiya J
    J Int Med Res; 1994; 22(1):63-6. PubMed ID: 8187946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Ristomycin, a new throbocyte aggregating agent. Comparative study of ristocetin and ristomycin (preliminary report)].
    Boda Z; Sztaricskai F; Rák K
    Orv Hetil; 1978 Jan; 119(5):259-61. PubMed ID: 203888
    [No Abstract]   [Full Text] [Related]  

  • 11. Ristocetin and platelet aggregation.
    Cattaneo M; Chiodini M; Mannucci PM
    Br J Haematol; 1989 Feb; 71(2):301-2. PubMed ID: 2923818
    [No Abstract]   [Full Text] [Related]  

  • 12. Diazo transfer-click reaction route to new, lipophilic teicoplanin and ristocetin aglycon derivatives with high antibacterial and anti-influenza virus activity: an aggregation and receptor binding study.
    Pintér G; Batta G; Kéki S; Mándi A; Komáromi I; Takács-Novák K; Sztaricskai F; Röth E; Ostorházi E; Rozgonyi F; Naesens L; Herczegh P
    J Med Chem; 2009 Oct; 52(19):6053-61. PubMed ID: 19791806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sebastian syndrome with abnormal platelet response to ristocetin.
    Redman R; Shunkwiler SM; Harris NS; Kedar A; Clapp WL
    Lab Hematol; 2008; 14(3):19-23. PubMed ID: 18812282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Letter: Ristocetin-induced platelet aggregation.
    Firkin BG; Howard M; Koutts J; Brodie GN; Stott L; Goh A
    Blood; 1975 Oct; 46(4):654-5. PubMed ID: 1174701
    [No Abstract]   [Full Text] [Related]  

  • 15. On the interaction between ristocetin and the ristocetin cofactor (RCOF).
    Floyd M; Burns W; Green D
    Thromb Res; 1977 Jun; 10(6):841-50. PubMed ID: 882968
    [No Abstract]   [Full Text] [Related]  

  • 16. Letter: Heparin and ristocetin-reduced platelet aggregation.
    Pekcelen Y; Inceman S
    Br Med J; 1975 Oct; 4(5988):101-2. PubMed ID: 1182460
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of platelet aggregation using light transmission and multiple electrode aggregometry in Glanzmann thrombasthenia.
    Awidi A; Maqablah A; Dweik M; Bsoul N; Abu-Khader A
    Platelets; 2009 Aug; 20(5):297-301. PubMed ID: 19548178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and synthesis of benzenesulfonanilides active against methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus.
    Namba K; Zheng X; Motoshima K; Kobayashi H; Tai A; Takahashi E; Sasaki K; Okamoto K; Kakuta H
    Bioorg Med Chem; 2008 Jun; 16(11):6131-44. PubMed ID: 18468909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of carbohydrate components of ristomycin A on platelet aggregation in human plasma].
    Trifonova ZhP; Sturman NV; Zheltova AO; Katrukha GS
    Antibiot Khimioter; 1989 Nov; 34(11):846-8. PubMed ID: 2633701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antibacterial activity in vitro of ristocetin, kanamycin and farmiglucine].
    Pierangeli L; Vellucci A; Tallarida G; Donati G
    Boll Soc Ital Biol Sper; 1964 Dec; 40(24):1662-3. PubMed ID: 5877895
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.